System and method for manufacturing monolithic structures using expanding internal tools
US-9498903-B2 · Nov 22, 2016 · US
US9492952B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9492952-B2 |
| Application number | US-201213435544-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 30, 2012 |
| Priority date | Aug 30, 2010 |
| Publication date | Nov 15, 2016 |
| Grant date | Nov 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A polydioxanone film comprising substantially cylindrical polydioxanone pillars on at least one side thereof, said pillars having diameters from about 0.2 μm to about 3 μm, and heights from about 2 μm to about 20 μm from the surface of the film, a process for adsorbing proteins using the film and medical devices incorporating the film.
Opening claim text (preview).
What is claimed: 1. A polydioxanone film comprising polydioxanone pillars having circular cross-sections integrally molded with and extending from the surface of at least one side of said film, said pillars having diameters from about 0.2 μm to about 3 μm, and heights of from about 2 μm to about 20 μm from the surface of the film, wherein the polydioxanone pillars demonstrate super-hydrophilicity. 2. The polydioxanone film of claim 1 , wherein the pillars are treated with an oxygen plasma to increase the oxygen content of said polydioxanone pillars, relative to untreated polydioxanone pillars. 3. The polydioxanone film of claim 2 , wherein the polydioxanone pillars have heights of about 20 μm from the surface of the film, having a static water contact angle of less than about 10°. 4. The polydioxanone film of claim 1 , wherein the polydioxanone pillars have diameters from about 0.6 μm to about 1 μμm, heights of about 20 μm from the surface of the film, having a static water contact angle of less than about 10°. 5. The polydioxanone film of claim 1 , which has a protein adsorption capacity from about 2.5 μg/cm 2 to about 6.0 μg/cm 2 of the film surface. 6. The polydioxanone film of claim 5 , which has a protein adsorption capacity from about 4.0 μg/cm 2 to about 6.0 μg/cm 2 of the film surface. 7. A process for adsorbing proteins, comprising exposing a protein-containing solution to a polydioxanone film comprising polydioxanone pillars having circular cross-sections integrally molded with and extending from the surface of at least one side of said film, said pillars having diameters from about 0.2 μm to about 3 μm, and heights from about 2 μm to about 20 μm from the surface of the film, wherein the polydioxanone pillars demonstrate super-hydrophilicity. 8. The process of claim 7 , wherein the pillars are treated with an oxygen plasma to increase the oxygen content of said polydioxanone pillars, relative to untreated polydioxanone pillars. 9. The process of claim 7 , wherein the polydioxanone pillars have diameters from about 0.6 μm to about 1 μm, heights of about 20 μm from the surface of the film, having a static water contact angle of less than about 10°. 10. The process of claim 8 , wherein the polydioxanone pillars have heights of about 20 μm from the surface of the film, having a static water contact angle of less than about 10°. 11. The process of claim 7 , wherein the polydioxanone film has a protein adsorption capacity from about 2.5 μg/cm 2 to about 6.0 μg/cm 2 of the film surface. 12. The process of claim 11 , wherein the polydioxanone film has a protein adsorption capacity from about 4.0 μg/cm 2 to about 6.0 μg/cm 2 of the film surface. 13. A medical device comprising a polydioxanone film comprising polydioxanone pillars having circular cross-sections integrally molded with and extending from the surface of at least one side of said film, said pillars having a diameter from about 0.2 μm to about 3 μm, and a height of up to about 2 μm to about 20 μm from the surface of the film, wherein the polydioxanone pillars demonstrate super-hydrophilicity. 14. The medical device of claim 13 , which has improved biocompatibility as compared to an implant device without said film. 15. The medical device of claim 13 , which has an increased capacity for protein adsorption as compared to a flat polydioxanone film.
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
soluble or fusible {(in particular used in injection moulding B29C45/4457)} · CPC title
adhesive · CPC title
hydrophobic · CPC title
hydrophilic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.